Loretta Que, MD
Enriched profileChief, Division of Pulmonary, Allergy, and Critical Care Medicine; Professor of Medicine · Duke University Hospital
Loretta Que is Chief, Division of Pulmonary, Allergy, and Critical Care Medicine; Professor of Medicine at Duke University Hospital. OpenAlex indexes 192 publications with 6,461 citations (h-index 38); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Loretta Que, MD, is Chief, Division of Pulmonary, Allergy, and Critical Care Medicine at Duke University Hospital. The public record shows 192 publications with 6,461 citations (h-index 38), centered on Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Occupational exposure and asthma. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 2 companies, 5 NIH-funded awards (2000–2023).
- Most recent indexed publication: 2026 · ERJ open research
- Top research focus: Asthma and respiratory diseases
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 70.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Sponsor: Johns Hopkins University
- Dual MRI for Cardiopulmonary COVID-19 Long Haulers
Sponsor: Bastiaan Driehuys
Industry payments
Updated 18 Oct 2026
2 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20254 payments$11,300openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20241 payment
- GENZYME CORPORATIONProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
78.3%Corticosteroid38.9%Trelegy Ellipta67%Symbicort13%Fluticasone Propionate11%Breo Ellipta10%Part D<11 patientsbeta2-Adrenergic Agonist16%Albuterol Sulfate Hfa82%Serevent Diskus19%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
12.8%Proton pump inhibitor6.4%Omeprazole100%Part D<11 patientsCorticosteroid6.4%Prednisone100%Part D≥11 patientsAnti-infectives
5.7%Macrolide Antimicrobial5.7%Azithromycin100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
5 NIH research awards on record, funded 2000–2023 per NIH RePORTER. The latest:
- Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma
Duke University
FY2023$737,246R01HL153641 - SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control
University of Colorado Denver
FY2023$700,666R01HL146542 - Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma
Duke University
FY2022$752,964R01HL153641
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Evaluation of the safety profile and intrapulmonary pharmacokinetics of intravenous fosfomycin in healthy adults.
Antimicrobial agents and chemotherapy
Clinical Trial2025 - Risk of Atherosclerotic Cardiovascular Disease After Chronic Obstructive Pulmonary Disease Hospitalization among Primary and Secondary Prevention Older Adults.
Journal of the American Heart Association
Article2025 - Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after Chronic Obstructive Pulmonary Disease Hospitalization among Older Adults.
Annals of the American Thoracic Society
Article2024 - Role of Paraoxonase 2 in Airway Epithelial Response to Oxidant Stress.
Antioxidants (Basel, Switzerland)
Article2024
Most-cited works
by citation count (OpenAlex)- 01A metabolic enzyme for S-nitrosothiol conserved from bacteria to humansArticle912 citations2001
- 02Essential Roles of S-Nitrosothiols in Vascular Homeostasis and Endotoxic ShockArticle547 citations2004
- 03
- 04
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
scholars.duke.edu/person/que00001/academic-experience
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗ - Other
dukehealth.org/find-doctors-physicians/loretta-g-que-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗ - Other
lung.org/our-initiatives/research/airways-clinical-research-centers/investigators-and-coordinators/loretta-que.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗
- Chief
Division of Pulmonary, Allergy, and Critical Care Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗ - Associate Editor
American Journal of Respiratory Cell and Molecular Biology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗ - Permanent Member
Lung Cellular and Molecular Immunology Study Section
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗ - Principal Investigator
American Lung Association Airways Clinical Research Center at Duke
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.duke.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Gilstrap, MD
Duke University Hospital
Susan Izatt
Duke University Hospital
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital